Rural Clinics Battle Mountain | |
825 N 2nd St Battle Mountain NV 89820-2834 | |
(775) 635-5753 | |
(775) 635-8028 |
Full Name | Rural Clinics Battle Mountain |
---|---|
Speciality | Clinic/center - Mental Health (including Community Mental Health Center) |
Location | 825 N 2nd St, Battle Mountain, Nevada |
Authorized Official Name and Position | Ellen Richardson-adams (AGENCY MANAGER) |
Authorized Official Contact | 7024864400 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Rural Clinics Battle Mountain Attn: Cyndi Smith 240 S. Humahuaca Pahrump NV 89048-2199 Ph: (775) 751-7406 | Rural Clinics Battle Mountain 825 N 2nd St Battle Mountain NV 89820-2834 Ph: (775) 635-5753 |
NPI Number | 1548350895 |
---|---|
Provider Enumeration Date | 10/14/2006 |
Last Update Date | 11/14/2022 |
Certification Date | 11/09/2022 |
Identifier | Type | State | Issuer |
---|---|---|---|
1548350895 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
261QM0801X | Clinic/center - Mental Health (including Community Mental Health Center) | (* (Not Available)) | Primary |
News Archive
Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced that the UK Intellectual Property Office (IPO) has rejected a revocation action brought by Biogene against three patents licensed exclusively to Enigma by the Defence Science and Technology Laboratory (Dstl), part of the UK Ministry of Defence.
Environmental health advocates hope that U.S. FDA will make its promised announcement about health hazards of bisphenol A (BPA), a synthetic sex hormone linked to cancer, behavioral changes, reproductive harm and other illnesses, in time for Christmas.
Scientists at Royal Holloway, University of London have developed a pioneering new method of oral vaccination which could help boost immunity to TB and influenza, as well as prevent C. difficile for which there is currently no vaccine.
Researchers from Boston University School of Medicine (BUSM) have identified a mechanism by which specific viruses acting as oncolytic agents can enter and kill cancer cells. This finding, which is currently featured in an online edition of the Journal of Virology, could help lead to the development of more targeted treatments against many types of cancer.
Research led by Jesse C. Stewart, Ph.D., of the School of Science at Indiana University-Purdue University Indianapolis, is the first to find that treatment of depression before any apparent signs of cardiovascular disease can decrease the risk of future heart attacks and strokes by almost half.
› Verified 5 days ago